December 28, 2012 — Accuray Inc. announced clinical findings using noninvasive CyberKnife stereotactic body radiation therapy (SBRT) for the treatment of prostate cancer. Two studies were presented at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston at a prostate-focused press conference, for which the use of CyberKnife SBRT for prostate cancer represented half of the press conference’s focus.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now